Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Revolution Medicines (RVMD) Tax Provisions (2020 - 2024)

Revolution Medicines (RVMD) has 4 years of Tax Provisions data on record, last reported at -$800000.0 in Q4 2024.

  • For Q4 2024, Tax Provisions fell 333.24% year-over-year to -$800000.0; the TTM value through Dec 2024 reached -$4.3 million, down 22.7%, while the annual FY2024 figure was -$800000.0, 77.3% up from the prior year.
  • Tax Provisions reached -$800000.0 in Q4 2024 per RVMD's latest filing, down from $343000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $362000.0 in Q4 2020 and bottomed at -$3.9 million in Q3 2023.
  • Average Tax Provisions over 4 years is -$586875.0, with a median of -$177500.0 recorded in 2020.
  • The widest YoY moves for Tax Provisions: up 15.49% in 2023, down 1202.02% in 2023.
  • A 4-year view of Tax Provisions shows it stood at $362000.0 in 2020, then fell by 17.96% to $297000.0 in 2022, then increased by 15.49% to $343000.0 in 2023, then crashed by 333.24% to -$800000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were -$800000.0 in Q4 2024, $343000.0 in Q4 2023, and -$3.9 million in Q3 2023.